 | Up a level |
Journal Article
Bosse, Autoren K., Faust, U., Gruber, I, Habhab, W., Guenther, G., Siebers-Renelt, U., Kiechle, M., Speiser, D., Dikow, N., Kast, K., Arnold, N., Vesper, A-S, Harbeck, N., Briest, S., Thomssen, C., Gehrig, A., Wallaschek, H., Solbach, C., Wolf, M., Witzel, I, Holzhauser, I, Kaulfuss, S., Janni, W., Engel, C., Riess, O., Schmutzler, R. and Schroeder, C. (2020). Clinical-pathological Characterization of 1078 Advice Seekers with pathogenic CHEK2 Mutation from the German Consortium of Familial Breast and Ovarian Cancer (DK-FBREK). Geburtshilfe Frauenheilkd., 80 (6). S. E23 - 2. STUTTGART: GEORG THIEME VERLAG KG. ISSN 1438-8804
Habhab, W., Faust, U., Guenther, G., Siebers-Renelt, U., Kiechle, M., Ott, C., Dikow, N., Kast, K., Vesper, A., Solbach, C., Harbeck, N., Stiller, M., Gehrig, A., Thomssen, C., Wallaschek, H., Arnold, N., Holzhauser, I., Kaulfuss, S., Volk, A., Janni, W., Engel, C., Schmutzler, R., Riess, O., Schroeder, C. and Bosse, K. (2020). Clinical and molecular characterization of 1253 carriers of a deleterious CHEK2 mutation from the German Consortium for Hereditary Breast and Ovarian Cancer (GC-HBOC). Eur. J. Hum. Genet., 28 (SUPPL 1). S. 93 - 95. LONDON: SPRINGERNATURE. ISSN 1476-5438
Neidhardt, G., Hauke, J., Heilmann, S., Hellebrand, H., Surowy, H. M., Klaschik, K., Honisch, E., Gehrig, A., Sutter, C., Rump, A., Bogdanova-Markov, N., Bugert, P., Mangold, E., Steinemann, D., Ramirez, A., Ditsch, N., Arnold, N., Niederacher, D., Burwinkel, B., Thiele, H., Altmueller, I., Nuernberg, P., Engel, C., Wappenschmidt, B., Rhiem, K., Meindl, A., Schmutzler, R. K. and Hahnen, E. (2016). Compelling evidence for FANCM as a breast cancer susceptibility gene. Oncol. Res. Treat., 39. S. 54 - 55. BASEL: KARGER. ISSN 2296-5262
Pohl, E., Borde, J., Hauke, J., Schmidt, S., Weber-Lassalle, K., Ernst, C., Niederacher, D., Arnold, N., Hellebrand, H., Meindl, A., Gehrig, A., Schmidt, G., Dutrannoy, V., Kast, K., Hahnen, E. and Schmutzler, R. (2018). Beyond CHEK2 in breast cancer: Search for additional moderately penetrant risk gene variants by analyzing the oligogenic disease course in CHEK2 mutation carriers. Eur. J. Hum. Genet., 26. S. 535 - 537. LONDON: NATURE PUBLISHING GROUP. ISSN 1476-5438